NCT03967223 2026-04-17IGNYTE-ESOUSWM, LLC (dba US WorldMeds)Phase 2 Active not recruiting103 enrolled
NCT06083883 2026-04-16Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1M.D. Anderson Cancer CenterPhase 1 Recruiting44 enrolled